Bioxytran, Inc. (BIXT)
OTCMKTS
· Delayed Price · Currency is USD
0.0326
-0.0006 (-1.69%)
Apr 28, 2026, 2:31 PM EST
Bioxytran Employees
Bioxytran had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,061,539
Market Cap
3.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AccuStem Sciences | 4 |
| ZIVO Bioscience | 7 |
| Mosaic ImmunoEngineering | 8 |
| Vaccinex | 27 |
| Orgenesis | 77 |
| CASI Pharmaceuticals | 233 |
Bioxytran News
- 5 weeks ago - BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT - GlobeNewsWire
- 7 weeks ago - Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M - GlobeNewsWire
- 2 months ago - Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19 - Accesswire
- 2 months ago - Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran - GlobeNewsWire
- 2 months ago - Bioxytran Transcript: Noble Capital Markets’ Emerging Growth Virtual Equity Conference - Transcripts
- 3 months ago - Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics - GlobeNewsWire
- 4 months ago - Bioxytran Transcript: Emerging Growth Conference 88 - Transcripts
- 5 months ago - Bioxytran Announces Initiation of Coverage of its Stock by Independent Research - GlobeNewsWire